ESC 365 - Tricuspid regurgitation and atrial fibrillation at baseline independently predict two-year survival after transcatheter aortic valve implantation (TAVI)

ESC Professional Premium Access

Tricuspid regurgitation and atrial fibrillation at baseline independently predict two-year survival after transcatheter aortic valve implantation (TAVI)

Session: Challenges in transcatheter aortic valve intervention

Topic: Intervention

Speaker: Professor M. Franz (Rotenburg an der Fulda, DE)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Professor Marcus Franz

Cardiovascular Center Rotenburg an der Fulda, Rotenburg an der Fulda (Germany)

0 follower

4 more presentations in this session

Man-machine interaction-based phenotyping preprocedurally identifies patients with severe aortic stenosis, who will not recover from cardiac damage following transcatheter aortic valve replacement

Speaker: Miss E. Rippen (Munich, DE)

Phenotyping patients with aortic stenosis using cluster analysis to determine mortality and suitability for transcatheter aortic valve replacement

Speaker: Doctor J. Sen (Melbourne, AU)

Prognostic relevance of mitral regurgitation at different follow-up timepoints after transcatheter aortic valve implantation (TAVI): implications for therapeutic decision making?

Speaker: Professor M. Franz (Rotenburg an der Fulda, DE)

Optimal protamine-to-heparin dosing ratio for the prevention of bleeding complications in patients undergoing TAVR - a multicentre experience

Speaker: Doctor B. Al-Kassou (Bonn, DE)

Access the full session

Challenges in transcatheter aortic valve intervention

Speakers: Professor M. Franz, Miss E. Rippen, Doctor J. Sen, Professor M. Franz, Doctor B. Al-Kassou

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources